Over-The-Counter Drug Monograph System - Past, Present and Future; Public Hearing

The U.S. Food and Drug Administration is announcing a public hearing to obtain input on the Over-The-Counter (OTC) Drug Review. FDA would like input on how to improve the current OTC Monograph Process for reviewing certain nonprescription drugs. This public hearing is being held to obtain information and comments from the public on the strengths and weaknesses of the current OTC Monograph Process, the feasibility of potential modifications the Agency has identified, and ideas about other modifications or alternatives to this process.


March 25-26, 2014


9:00 a.m. to 4:00 p.m.


FDA White Oak Campus
10903 New Hampshire Avenue
Bldg. 31, Room 1503 (Great Room)
Silver Spring, Maryland 20993

Registration to Attend the Workshop:

Register to attend or provide oral testimony at the meeting by submitting electronic requests to CDEROTCMONOGRAPH@fda.hhs.gov by March 12, 2014. Written or electronic comments to the docket has been extended until July 31, 2014.


Page Last Updated: 12/10/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English